GEN Exclusives

More »

GEN News Highlights

More »
Nov 1, 2006

Galapagos and LEO Pharma Collaborate on Antibacterial Research

  • BioFocus, Galapagos' service division, will use a subset of its natural compound collection for high-throughput screening, hit verification, and profiling of selected compounds for LEO Pharma's antibacterial research program. This collaboration marks Galapagos' first for its natural compound collection.

    Galapagos stands to receive up to EUR 400,000 in project fees and up to EUR 3 million in milestone payments. The company may also receive royalties on sales of commercial products resulting from the collaboration. 

    BioFocus says its natural compound collections are based on bacterial and fungal sources, offering characteristics differentiating these from synthetic chemistry collections, including high chemical and functional diversity, potent pharmacological activities over a broad range of biological targets, and desirable physicochemical properties.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Children and Antipsychotic Drugs

Do you think children and adolescents with behavioral problems are overmedicated?